Sponsor or institution
Clinical trials and research at Basilea Pharmaceutica
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Basilea Pharmaceutica that are recruiting, at sites in 22 countries (most in United States (4), Netherlands (3), Australia (2)). 2 were first registered in the last 30 days. By phase: Phase 1 (4), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2New in 30 days
- 22Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How the body handles fosmanogepix in adults on dialysis | Phase 1 | Orlando, Florida and 1 other locations | Recruiting | Nov 4, 2026 |
| Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm | Phase 1 | Groningen, Netherlands | Recruiting | Oct 19, 2026 |
| BAL2420 safety and dosing in healthy adults | Phase 1 | Groningen | Recruiting | Mar 30, 2026 |
| Fosmanogepix treatment for adults with invasive mold infections | Phase 3 | Birmingham, Alabama and 89 other locations | Recruiting | Apr 13, 2025 |
| Safety and blood-level testing of an oral fixed-dose combo of ceftibuten and ledaborbactam etzadroxil | Phase 1 | Lenexa, Kansas | Recruiting | Dec 13, 2024 |
| Treatment of serious fungal infections with Fosmanogepix | Phase 3 | Birmingham, Alabama and 145 other locations | Recruiting | Jun 16, 2022 |
All recruiting trials (6)
-
How the body handles fosmanogepix in adults on dialysis
This study tests how fosmanogepix behaves in the body and its safety in adults with end-stage kidney disease on dialysis, compared to people with normal kidney function.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
-
BAL2420 safety and dosing in healthy adults
This trial will test how safe BAL2420 is and how the body absorbs and clears different single and repeated doses in healthy adult volunteers.
-
Fosmanogepix treatment for adults with invasive mold infections
This trial tests whether fosmanogepix (given IV or as a pill) is safe and works to treat adults with invasive mold infections, either compared with usual antifungals or as a salvage option after other treatments fail.
-
Safety and blood-level testing of an oral fixed-dose combo of ceftibuten and ledaborbactam etzadroxil
This will test the safety and how the body processes an oral fixed-dose combination of ceftibuten and ledaborbactam etzadroxil in healthy adults aged 18–55.
-
Treatment of serious fungal infections with Fosmanogepix
This study is testing if a new treatment called Fosmanogepix can help people with serious fungal infections like candidemia and invasive candidiasis do better than the usual treatments.
Quick answers
How many clinical trials run by Basilea Pharmaceutica are recruiting right now?
6, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 22 countries. The most sites are in United States (4 trials), Netherlands (3 trials), Australia (2 trials), Austria (2 trials), Belgium (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.